Raloxifene in Preventing Breast Cancer in Premenopausal Women

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of raloxifene may be an effective way to prevent breast cancer in premenopausal women. PURPOSE: Phase II trial to study the effectiveness of raloxifene in preventing invasive breast cancer in premenopausal women.

Key facts

Study ID

NCT00019500

Run by

National Cancer Institute (NCI)

Starts

1998-12-01

Expected to finish

2005-06-01

Last updated by the study team

2013-06-20

Who can join

Age: 23 and older, up to 47. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Medicine Branch — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.